21 C.F.R. § 556.308

Halofuginone.

Last amended: 2019Year: 2026Length: 55 wordsSubsections: 3Official source

Cite as 21 C.F.R. § 556.308 (2026)

(a) Acceptable daily intake (ADI). The ADI for total residue of halofuginone hydrobromide is 0.7 µg/kg of body weight per day. (b) Tolerances. The tolerances for halofuginone (marker residue) are: (1) Chickens. Liver (target tissue): 0.16 ppm. (2) Turkeys. Liver (target tissue): 0.13 ppm. (c) Related conditions of use. See § 558.265 of this chapter.
Cross-references to the CFR
558.265
21 C.F.R. § 556.308: Halofuginone. | Justis AI